drugset / Trial / NCT02285283

Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps

NCT02285283

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this randomized controlled double-blinded trial is to determine if the addition of an oral antifungal to typical post-operative medical therapy can prevent or reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Timeline

Start
2014-11
Primary completion
2019-05-15
Completion
2019-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Itraconazole Small molecule 200 mg Oral